These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25546756)

  • 1. Immunoglobulin (Ig) in multifocal motor neuropathy (MMN): update on evidence for Ig treatment in MMN.
    Léger JM
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):42-4. PubMed ID: 25546756
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of intravenous immunoglobulin in multifocal motor neuropathy.
    Leger JM; Vargas S; Lievens I
    Ann N Y Acad Sci; 2007 Sep; 1110():248-55. PubMed ID: 17911439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifocal motor neuropathy: current therapies and novel strategies.
    Nobile-Orazio E; Gallia F
    Drugs; 2013 Apr; 73(5):397-406. PubMed ID: 23516024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of multifocal motor neuropathy with intravenous immunoglobulin.
    Koski CL
    J Clin Immunol; 2014 Jul; 34 Suppl 1():S127-31. PubMed ID: 24699885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies.
    Lehmann HC; Hartung HP
    J Neuroimmunol; 2011 Feb; 231(1-2):61-9. PubMed ID: 21056913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMN: from immunological cross-talk to conduction block.
    Harschnitz O; Jongbloed BA; Franssen H; Straver DC; van der Pol WL; van den Berg LH
    J Clin Immunol; 2014 Jul; 34 Suppl 1(Suppl 1):S112-9. PubMed ID: 24728842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's new in multifocal motor neuropathy in 2007-2008?
    Nobile-Orazio E
    J Peripher Nerv Syst; 2008 Dec; 13(4):261-3. PubMed ID: 19192064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical usefulness of high-dose intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy].
    Kubori T; Mezaki T; Kaji R; Kimura J; Hamaguchi K; Hirayama K; Kanazawa I; Miyatake T; Mannen T; Kowa H; Yanagisawa N; Goto I; Osame M; Kanda M; Tashiro K; Baba M; Kuroiwa Y; Nagatomo H; Mitsuma T; Shigeta Y; Saida T; Nakajima K; Kawamura J; Murai Y; Kiuchi T
    No To Shinkei; 1999 Feb; 51(2):127-35. PubMed ID: 10198901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin therapy in the treatment of multifocal motor neuropathy.
    Kumar A; Patwa HS; Nowak RJ
    J Neurol Sci; 2017 Apr; 375():190-197. PubMed ID: 28320129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label trial of rituximab (Rituxan®) in multifocal motor neuropathy.
    Chaudhry V; Cornblath DR
    J Peripher Nerv Syst; 2010 Sep; 15(3):196-201. PubMed ID: 21040141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multifocal Motor Neuropathy].
    Kanda S; Kanda T
    Brain Nerve; 2024 May; 76(5):526-533. PubMed ID: 38741492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune pathogenesis and treatment of multifocal motor neuropathy.
    Vlam L; van den Berg LH; Cats EA; Piepers S; van der Pol WL
    J Clin Immunol; 2013 Jan; 33 Suppl 1():S38-42. PubMed ID: 22941513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How long is IVIg effective in multifocal motor neuropathy?
    Terenghi F; Cappellari A; Bersano A; Carpo M; Barbieri S; Nobile-Orazio E
    Neurology; 2004 Feb; 62(4):666-8. PubMed ID: 14981195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy.
    Hahn AF; Beydoun SR; Lawson V; ; Oh M; Empson VG; Leibl H; Ngo LY; Gelmont D; Koski CL
    J Peripher Nerv Syst; 2013 Dec; 18(4):321-30. PubMed ID: 24725024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human polyvalent immunoglobulin: new indication. Multifocal motor neuropathy: slightly more muscle strength. Improvement in muscle strength, but frequent hypersensitivity reactions.
    Prescrire Int; 2009 Apr; 18(100):62. PubMed ID: 19585721
    [No Abstract]   [Full Text] [Related]  

  • 17. [Update of multifocal motor neuropathy].
    Matsui N; Miyashiro A; Kaji R
    Nihon Rinsho; 2013 May; 71(5):861-4. PubMed ID: 23777095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra-high dose of intravenous immunoglobulin restores strength and motor function in a patient with refractory multifocal motor neuropathy.
    Saucedo M; León-Cejas L; Marchesoni C; Pardal A; Reisin R
    Rev Neurol; 2023 Mar; 76(6):209-211. PubMed ID: 36908034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospects.
    Rajabally YA
    J Neurol Neurosurg Psychiatry; 2014 Jun; 85(6):631-7. PubMed ID: 24124042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of chronic immune-mediated polyneuropathies. State of the art and perspectives].
    Léger JM; Chassande B
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S19-23. PubMed ID: 10896984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.